Skip to content

DexCom DXCM Total Equity

Total Equity at other companies

Cabot Corporation logo
Cabot CorporationCBT
$1.57B+9.9%
Main Street Capital logo
Main Street CapitalMAIN
$3.09B+8.9%
Belden logo
BeldenBDC
$1.28B+4.9%
Sharplink, Inc.
 logo
Sharplink, Inc. SBET
$1.74B+83,286%
Middlesex Water Company logo
Middlesex Water CompanyMSEX
$501.05M+11.6%
US Physical Therapy logo
US Physical TherapyUSPH
$468.98M-5.7%

Other financials

Income statement

See full
Revenue$1.2B+15.0%
Gross profit$750.3M+27.4%
Operating income$255.3M+90.9%
Net income$199.5M+89.3%
EPS (diluted)$0.51+88.9%

Balance sheet

See full
Cash & equivalents$1.1B+23.4%
Total debt$143.0M+2.2%
Total assets$6.6B-1.8%

Cash flow

See full
Operating cash flow$525.6M+186%
CapEx$76.6M-12.0%
Free cash flow$449.0M+364%

Valuation

See full
Market cap$25.99B-17.5%
Enterprise value$25.01B-17.9%
P/E27.9×-27.2×
P/S5.4×-1.9×

Profitability

See full
Gross margin61.5%+2.1pp
Operating margin21.4%+6.2pp
Net margin19.3%+6.4pp
FCF margin29.7%+15.8pp

Returns & leverage

See full
Return on equity35.6%+11.9pp
Debt / equity0.0×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by DexCom in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: DexCom’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about DexCom's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DexCom's total equity?
DexCom (DXCM) reported total equity of $2.96B in Q1 2026.
How has DexCom's total equity changed year-over-year?
DexCom's total equity increased by 30.5% year-over-year, from $2.27B to $2.96B.
What is the long-term trend for DexCom's total equity?
Over 5 years (2020 to 2025), DexCom's total equity has grown at a 12.1% compound annual growth rate (CAGR), from $1.55B to $2.75B.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.